← Back to Clinical Trials
Recruiting Phase 4 NCT05454891

Extended Bolus for Meals in a Closed-loop System

Trial Parameters

Condition Type 1 Diabetes
Sponsor University of California, San Francisco
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 30
Sex ALL
Min Age 13 Years
Max Age 19 Years
Start Date 2022-07-15
Completion 2025-07-30
Interventions
Extended bolus of insulin then standard bolus of insulinStandard bolus of insulin then extended bolus of insulin

Brief Summary

This study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained from this study may provide a method to allow for the proper administration of insulin over an extended period to mitigate the risk of prolonged hyperglycemia or early hypoglycemia.

Eligibility Criteria

Inclusion Criteria * Age between 13 and 19 years old, A1C \> 6% at screening * Diagnosed with type 1 diabetes for at least one year * Total daily dose (TDD) of insulin ≥ 0.3 units/kg/day * Currently using the Control IQ closed-loop system * Willing to abide by meal recommendations and study procedures * Willing and able to sign the Informed Consent Form (ICF) and/or has a parent or guardian willing and able to sign the ICF * Use an Android or Apple smartphone * Willingness not to start any new non-insulin glucose-lowering agent during the course of the trial * Participant and parent(s)/guardian(s) willingness to participate in all training sessions as directed by study staff * Parent/guardian proficient in reading and writing English * Live in the United States, with no plans to move outside the United States during the study period Exclusion Criteria * A1C \>10% * One or more episodes of severe hypoglycemia or DKA requiring ER visit or hospitalization within the past three months * Us

Related Trials